| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.52 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |